Holland - hollandi - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sandoz b.v. veluwezoom 22 1327 ah almere - metoprololtartraat 50 mg/stuk - tablet - calciumwaterstoffosfaat 2-water (e 341) ; cellulose, microkristallijn (e 460(i)) ; crospovidon (e 1202) ; hyprolose (e 463) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; siliciumdioxide (e 551), calciumwaterstoffosfaat 2-water (e 341) ; cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; hyprolose (e 463) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; siliciumdioxide (e 551), - metoprolol

Holland - hollandi - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

pharmachemie b.v. - metoprololtartraat samenstelling overeenkomend met; metoprolol; - tablet met verlengde afgifte - metoprolol

Rootsi - rootsi - Läkemedelsverket (Medical Products Agency)

laboratoires thea - diklofenaknatrium - Ögondroppar, lösning - 1 mg/ml - diklofenaknatrium 1 mg aktiv substans; bensalkoniumklorid hjälpämne; hydroxipropyl-gamma-cyklodextrin hjälpämne; propylenglykol hjälpämne - diklofenak

Rootsi - rootsi - Läkemedelsverket (Medical Products Agency)

laboratoires thea - diklofenaknatrium - Ögondroppar, lösning i endosbehållare - 1 mg/ml - makrogolglycerolricinoleat hjälpämne; borsyra hjälpämne; diklofenaknatrium 1 mg aktiv substans - diklofenak

Singapur - inglise - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - diclofenac sodium - solution - 1 mg/ml - diclofenac sodium 1 mg/ml

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

thea pharmaceuticals ltd - diclofenac sodium - eye drops - 1mg/1ml

Norra - norra - Statens legemiddelverk

macure pharma aps - metoprololtartrat - injeksjonsvæske, oppløsning - 1 mg/ ml

Holland - hollandi - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

centrafarm b.v. van de reijtstraat 31-e 4814 ne breda - metoprololtartraat 200 mg/stuk - tablet met gereguleerde afgifte - ammoniomethacrylaatcopolymeer type b ; hypromellose (e 464) ; lactose 1-water ; macrogol 4000 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - metoprolol

Hispaania - hispaania - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratoires thea - diclofenaco sodico - excipientes: macrogolglicerol, ricinoleato de - agentes antiinflamatorios - agentes antiinflamatorios no esteroideos - diclofenaco

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

rebel distributors corp - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 10 mg in 1 g - voltaren® gel is indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands. - voltaren® gel has not been evaluated for use on the spine, hip, or shoulder. the use of voltaren® gel is contraindicated in patients with a known hypersensitivity to diclofenac. voltaren® gel should not be administered in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients [see warnings and precautions (5.1)]. voltaren® gel is contraindicated in the setting of coronary artery bypass graft (cabg) surgery [see   warnings and precautions (5.1 )] . the safety of voltaren® gel has not been established during pregnancy. there are no well-controlled studies of diclofenac in pregnant women. human and animal studies indicate that diclofenac crosses the placenta. in late pregnancy, as with other nsaids,